- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Castration resistant carcinoma of the prostate
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Abiraterone Acetate and Prednisolone – July 2025
Abiraterone Acetate and Prednisolone; Pack containing 56 tablets abiraterone acetate 500 mg and 56 tablets prednisolone 5 mg; Andriga-10
Last updated
9 July 2025